Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)

CompletedOBSERVATIONAL
Enrollment

713

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Hepatitis C Chronic
All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01544582 - Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518) | Biotech Hunter | Biotech Hunter